Earlier this month the FDA approved Rexulti (Brexpiprazole) for the treatment of agitation in patients with dementia due to Alzheimer’s. Originally approved as an atypical antipsychotic used for schizophrenia, or an adjunct therapy for major depressive disorder,...
In this case study, I highlight the clinical impact that the ciprofloxacin and zolpidem interaction can have on a patient. JS is a 58-year-old female with a history of insomnia and takes zolpidem 10 mg at bedtime every night. She has recently been diagnosed with a...
One thing I always encourage is critical thinking. Reviewing a diagnosis list will give you clues as to the likely medications that a patient is taking or should be taking if they are following guideline-based medication therapy. In this Bactrim CHF case study, I...
Polypharmacy is something I’m extremely passionate about. In my work as a consultant pharmacist, there isn’t a much better feeling for me than eliminating medications that the patient doesn’t need. To successfully minimize polypharmacy (check out my...
This article was originally written by Christine Meyer, MD and I found this story too good not to share. I’m appreciative to her for letting me share it. Deprescribing and dose reductions require all hands on deck. Kudos to all of you pharmacists out there doing...